![Uwe Klein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uwe Klein
Corporate Officer/Principal bij
SEPTERNA, INC.
Vermogen: 4 M $ op 31-07-2026
Profiel
Uwe Klein currently works at Septerna, Inc., as Senior Vice President-Biological Sciences from 2021.
Dr. Klein also formerly worked at Theravance Biopharma, Inc., as Senior Director-Molecular & Cellular Biology from 1998 to 2014, Bristol Myers Squibb Co., as Vice President-Biology from 2020 to 2021, MyoKardia, Inc., as Vice President-Biology from 2019 to 2020, and Numerate, Inc., as Vice President-Biology from 2014 to 2019.
Dr. Klein received his undergraduate degree, graduate degree, and doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SEPTERNA, INC. 0,28% | 06-02-2026 | 127.533 ( 0,28% ) | 4 M $ | 31-07-2026 |
Actieve functies van Uwe Klein
| Bedrijven | Functie | Begin |
|---|---|---|
| SEPTERNA, INC. | Corporate Officer/Principal | 01-08-2021 |
Eerdere bekende functies van Uwe Klein
| Bedrijven | Functie | Einde |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-03-2021 |
| MYOKARDIA, INC. | Corporate Officer/Principal | 01-11-2020 |
Numerate, Inc.
 Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Corporate Officer/Principal | 01-09-2019 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01-10-2014 |
Opleiding van Uwe Klein
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Numerate, Inc.
Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Technology Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
